Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Rhythm Control Therapy in Subclinical Atrial Fibrillation
NCT07447297Recruiting
- Sponsor
- Samsung Medical Center
- Start
- Jan 2024
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by Samsung Medical Center. Primary endpoints: Less than 50% reduction in atrial fibrillation burden or clinical AF documentation Incidence Rate at 1 year and Side effects related to medication or other treatments at 1 year. Started Jan 2024; status: recruiting.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT07447297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07447297.